---
trigger: always_on
description: >
---


# OpenPGx Research — Gene/SNP Study Generator

You are creating structured pharmacogenomic (PGx) and nutrigenomic study files for the OpenPGx open-source catalog. Each file represents one gene-drug or gene-trait association backed by peer-reviewed evidence.

## Project Layout

```
mcp-server/
├── data/pgx/studies/          ← study JSONs go here
├── docs/
│   ├── openpgx.schema.json         ← patient file schema (v0.4.0)
│   └── openpgx.study.schema.json   ← study contribution schema (v0.4.0)
├── scripts/validate_studies.py      ← validation script
└── TODO-RESEARCH.md           ← master list of pending genes
```

**Schema lives in `mcp-server/docs/openpgx.study.schema.json`** — single source of truth.

## Workflow Overview

```
1. DISCOVER  →  2. RESEARCH  →  3. GENERATE  →  4. VALIDATE  →  5. UPDATE TODO
```

---

## Phase 1: DISCOVER — What needs to be built?

- **If user names specific genes**: collect gene symbols, rsIDs, drugs, and category.
- **If user says "do all from TODO"**: read `mcp-server/TODO-RESEARCH.md` and filter unchecked items.
- **If user provides a report/PDF**: extract gene+rsID pairs from the document.

### Checklist before proceeding

- [ ] Gene symbol (HGNC standard, e.g., `CYP2D6` not `cyp2d6`)
- [ ] At least one rsID
- [ ] Associated drugs or traits
- [ ] Category (drug_metabolism, drug_target, drug_transport, immune, nutrient_absorption, etc.)

### Check for duplicates

```bash
ls mcp-server/data/pgx/studies/ | grep -i <gene_name_lowercase>
```

If a study exists, user might want an *upgrade* (add more SNPs/drugs) rather than a new file. Ask.

---

## Phase 2: RESEARCH — Gather evidence

Run **parallel web searches** for each gene:

```
"<GENE> <rsID> <key_drug_or_trait> pharmacogenomics <functional_keyword> allele frequency"
```

### Data points to extract

| Data point | Source | Required? |
|---|---|---|
| Mechanism | PharmGKB, gene reviews | Yes |
| Risk allele | Primary GWAS or PGx study | Yes |
| Reference allele | Same source or dbSNP | Yes |
| Clinical effect per genotype | CPIC/DPWG guidelines | Yes |
| Recommendations per genotype | CPIC, FDA label | Yes |
| Severity per genotype | Clinical judgment | Yes |
| PMID / DOI | PubMed | Yes |
| Odds ratio | Meta-analysis | Nice to have |
| Population frequencies | gnomAD, 1000 Genomes | Nice to have |
| Cohort size | Study abstract | Nice to have |

### Evidence level classification

| Level | Criteria |
|---|---|
| `established` | CPIC Level A/B, PharmGKB 1A/1B, FDA label, multiple large meta-analyses |
| `moderate` | PharmGKB 2A/2B, single large meta-analysis, consistent replicated GWAS |
| `emerging` | PharmGKB Level 3, single well-powered study, GWAS without replication |
| `preliminary` | Small cohort, candidate gene study, conflicting evidence |

### Research sources (by tier)

**Tier 1 — Authoritative (prefer these):**
- CPIC Guidelines (cpicpgx.org/guidelines/)
- PharmGKB (pharmgkb.org/gene/GENE)
- DPWG Dutch guidelines (pharmgkb.org/page/dpwg)
- FDA Pharmacogenomic Biomarkers Table

**Tier 2 — Strong evidence:**
- PubMed meta-analyses
- gnomAD (gnomad.broadinstitute.org) — population allele frequencies
- ClinVar (ncbi.nlm.nih.gov/clinvar)
- SNPedia (snpedia.com)

**Tier 3 — Supplementary:**
- dbSNP, GeneCards, OMIM, 1000 Genomes

### Common pitfalls

1. Don't confuse risk/reference alleles — cross-reference with dbSNP.
2. Population frequencies are ALLELE frequencies (0-1), not genotype frequencies.
3. Always include both heterozygous orderings (AG and GA).
4. For HLA genes, the rsID may be a tag SNP — clarify in effect text.
5. For haplotypic genes (APOE), create entries for BOTH rsIDs.
6. Source URL: always `https://pubmed.ncbi.nlm.nih.gov/<PMID>/`

---

## Phase 3: GENERATE — Create JSON study files

### File naming: `<gene_lowercase>_<year>_<short_description>.json`

### JSON template (canonical: `docs/openpgx.study.schema.json`)

```json
{
  "gene": "GENE_SYMBOL",
  "category": "category_here",
  "gene_description": "One-sentence description of gene function and clinical relevance",
  "drugs": ["drug1", "drug2"],
  "source": {
    "pmid": "12345678",
    "doi": "10.xxxx/xxxxx",
    "source_type": "pubmed",
    "title": "Full title of the primary paper",
    "journal": "Journal Name",
    "year": 2024,
    "cohort_size": null,
    "url": "https://pubmed.ncbi.nlm.nih.gov/12345678/",
    "finding": "One-line summary with specific numbers"
  },
  "snps": [
    {
      "rsid": "rs12345",
      "risk_allele": "A",
      "reference_allele": "G",
      "interpretations": {
        "AA": { "phenotype": "...", "effect": "...", "recommendation": "...", "severity": "moderate", "odds_ratio": null },
        "AG": { "phenotype": "...", "effect": "...", "recommendation": "...", "severity": "mild" },
        "GA": { "phenotype": "...", "effect": "...", "recommendation": "...", "severity": "mild" },
        "GG": { "phenotype": "...", "effect": "...", "recommendation": "...", "severity": "info" }
      },
      "population_frequency": { "european": 0.10, "african": 0.05, "east_asian": 0.15, "south_asian": 0.08, "latino": 0.09 }
    }
  ],
  "evidence_level": "moderate",
  "contributor": { "name": "OpenPGx Community", "github": "openpgx" }
}
```

### Writing quality

- **gene_description**: Full gene name + dash + clinical function (<200 chars)

<!-- Content truncated to meet Windsurf 6KB limit -->

---
> Source: [open-pgx/openpgx](https://github.com/open-pgx/openpgx) — distributed by [TomeVault](https://tomevault.io).
<!-- tomevault:4.0:windsurf_rules:2026-04-24 -->
